Literature DB >> 10668347

[Sense and nonsense of post-authorization surveillance].

C de Mey1.   

Abstract

Mesh:

Year:  2000        PMID: 10668347     DOI: 10.1007/bf03044984

Source DB:  PubMed          Journal:  Med Klin (Munich)        ISSN: 0723-5003


× No keyword cloud information.
  4 in total

Review 1.  [Therapeutic indications: on the concept and applications].

Authors:  A Koch; J Windeler; U Abel
Journal:  Med Klin (Munich)       Date:  1996-02-15

Review 2.  Company observational post-marketing studies: drug risk assessment and drug research in special populations--a study-based analysis.

Authors:  J Hasford; T Lamprecht
Journal:  Eur J Clin Pharmacol       Date:  1998-01       Impact factor: 2.953

Review 3.  [Planning, realization and evaluation of post-marketing surveillance studies. Recommendations of the Society for Phytotherapy].

Authors:  K Kraft; D Loew; B Schneider; F H Kemper
Journal:  Arzneimittelforschung       Date:  1997-08

4.  [Guidelines for carrying out application studies in psychopharmacotherapy. "Phase IV Research" Study Group of the Society of Neuropsychopharmacology and Pharmacopsychiatry].

Authors:  M Linden; D Baier; H Beitinger; R Kohnen; M Osterheider; M Philipp; P E Reimitz; B Schaaf; H J Weber
Journal:  Nervenarzt       Date:  1994-09       Impact factor: 1.214

  4 in total
  1 in total

1.  A 1-year cross-sectional analysis of non-interventional post-marketing study protocols submitted to the German Federal Institute for Drugs and Medical Devices (BfArM).

Authors:  Beatrice K J G von Jeinsen; Thomas Sudhop
Journal:  Eur J Clin Pharmacol       Date:  2013-03-20       Impact factor: 2.953

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.